Polaris Group (6550.TW)

TWD 30.3

(-0.33%)

Gross Profit Summary of Polaris Group

  • Polaris Group's latest annual gross profit in 2023 was -137.9 Million TWD , up 2.79% from previous year.
  • Polaris Group's latest quarterly gross profit in 2024 Q2 was -3.63 Million TWD , up 90.24% from previous quarter.
  • Polaris Group reported a annual gross profit of -141.86 Million TWD in annual gross profit 2022, up 5.82% from previous year.
  • Polaris Group reported a annual gross profit of -150.62 Million TWD in annual gross profit 2021, down -15.17% from previous year.
  • Polaris Group reported a quarterly gross profit of -3.63 Million TWD for 2024 Q2, up 90.24% from previous quarter.
  • Polaris Group reported a quarterly gross profit of -34.09 Million TWD for 2023 Q4, down -16.56% from previous quarter.

Annual Gross Profit Chart of Polaris Group (2023 - 2016)

Historical Annual Gross Profit of Polaris Group (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 -137.9 Million TWD 2.79%
2022 -141.86 Million TWD 5.82%
2021 -150.62 Million TWD -15.17%
2020 -130.78 Million TWD 5.47%
2019 -138.34 Million TWD -25.19%
2018 -110.51 Million TWD 2.88%
2017 -113.79 Million TWD 11.2%
2016 -128.13 Million TWD 0.0%

Peer Gross Profit Comparison of Polaris Group

Name Gross Profit Gross Profit Difference
Apex Biotechnology Corp. 531.11 Million TWD 125.964%
Sinphar Pharmaceutical Co.,Ltd. 1.09 Billion TWD 112.637%
Panion & Bf Biotech Inc. 912.56 Million TWD 115.111%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 757.3 Million TWD 118.209%
GenMont Biotech Incorporation 177.33 Million TWD 177.763%
Abnova (Taiwan) Corporation 173.91 Million TWD 179.292%
Adimmune Corporation 410.93 Million TWD 133.558%
Tanvex BioPharma, Inc. 59.7 Million TWD 330.986%
Energenesis Biomedical CO.,LTD. 5.22 Million TWD 2738.244%
UnicoCell Biomed Co., Ltd. 17.89 Million TWD 870.526%
PELL Bio-Med Technology Co. Ltd. -26.14 Million TWD -427.548%